---
category: news
title: "BioXcel Therapeutics Receives FDA Clearance of IND for Phase 2 Trial with BXCL501 for the ..."
excerpt: "(GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (“BTI” or “Company”) (Nasdaq: BTAI), a clinical-stage biopharmaceutical company utilizing artificial intelligence to identify improved therapies in neuroscience and immuno-oncology,"
publishedDateTime: 2020-10-26T11:00:00Z
originalUrl: "https://apnews.com/press-release/globenewswire-mobile/business-virus-outbreak-products-and-services-government-regulations-drug-approvals-0d95867f6e57b4b45ad286988f784c9f"
webUrl: "https://apnews.com/press-release/globenewswire-mobile/business-virus-outbreak-products-and-services-government-regulations-drug-approvals-0d95867f6e57b4b45ad286988f784c9f"
type: article
quality: 13
heat: 13
published: false

provider:
  name: Associated Press
  domain: apnews.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://apnews.com/images/PaidContent3.png"
    width: 700
    height: 450
    isCached: true

secured: "YNm5/seSyUekakO2CVDpjwLzS0UVkFzubEosm1XlBxlWYmymuKrHAh80re0vEVYcWclMATGH8zrjngmwSUDuZQiJxuMD4ejET9P01zXBNhWsmq97E16xHQVT9MllnkBILjS9dIdSbgY2GEfrg3lFicz8LnPnV+UKVJb8lYlma8tohDBFyHASgryIfHcxfgdLfTepIpJLdPRGBojLHUGziK3W/EOsufjzaadVcwXZbwH5an96Dot53A1us1J/OrHkmxbTb2OBQXlf0+sCWtz32VXgsqly531k1eeJV8hYTvALgxXzDazYf5mxCVmteWD10poDSWYF656RLDEiaWJtJaIBwC/CPU/C5KDnxN+sd58=;zpaj1G6SlnAM5Jq/Gem1XA=="
---

